FIM
INSY

Freedom Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Freedom Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-66,059
Closed -$399K – 1196
2018
Q1 		$399K Buy
66,059
+1,318
+2% +$10.9K 0.02% 755
2017
Q4 		$623K Buy
64,741
+1,709
+3% +$11.2K 0.03% 534
2017
Q3 		$560K Sell
63,032
-3,089
-5% -$31.9K 0.03% 541
2017
Q2 		$836K Buy
66,121
+404
+0.6% +$4.78K 0.05% 384
2017
Q1 		$691K Sell
65,717
-7,476
-10% -$79.7K 0.04% 422
2016
Q4 		$673K Sell
73,193
-19,470
-21% -$220K 0.04% 386
2016
Q3 		$1.09M Sell
92,663
-2,111
-2% -$32.1K 0.07% 219
2016
Q2 		$1.23M Buy
94,774
+5,600
+6% +$81.6K 0.08% 171
2016
Q1 		$1.43M Buy
+89,174
New +$1.69M 0.1% 135

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Freedom Investment Management's INSY Position: Q2 2018 in Review

Freedom Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2018, closing a stake of 66,059 shares — an estimated $399K sold.

Freedom Investment Management first reported a position in INSY in Q1 2016 and held it in 9 quarters. The position peaked at $1.43M in Q1 2016. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

  • Freedom Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Freedom Investment Management sold 66,059 Insys Therapeutics, Inc. shares in Q2 2018, an estimated $399K.
  • Freedom Investment Management first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 9 quarters.
  • Freedom Investment Management's Insys Therapeutics, Inc. position peaked at $1.43M in Q1 2016.
  • 103 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2018.

Based on Freedom Investment Management's 13F filing for Q2 2018, filed 27 Jul 2018.